Cargando…

Comparison of HIV-1 Genotypic Resistance Test Interpretation Systems in Predicting Virological Outcomes Over Time

BACKGROUND: Several decision support systems have been developed to interpret HIV-1 drug resistance genotyping results. This study compares the ability of the most commonly used systems (ANRS, Rega, and Stanford's HIVdb) to predict virological outcome at 12, 24, and 48 weeks. METHODOLOGY/PRINCI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frentz, Dineke, Boucher, Charles A. B., Assel, Matthias, De Luca, Andrea, Fabbiani, Massimiliano, Incardona, Francesca, Libin, Pieter, Manca, Nino, Müller, Viktor, Nualláin, Breanndán Ó., Paredes, Roger, Prosperi, Mattia, Quiros-Roldan, Eugenia, Ruiz, Lidia, Sloot, Peter M. A., Torti, Carlo, Vandamme, Anne-Mieke, Van Laethem, Kristel, Zazzi, Maurizio, van de Vijver, David A. M. C.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2901338/ https://www.ncbi.nlm.nih.gov/pubmed/20634893 http://dx.doi.org/10.1371/journal.pone.0011505

Ejemplares similares

Extracting causal relations on HIV drug resistance from literature
por: Bui, Quoc-Chinh, et al.
Publicado: (2010)

Superinfection with drug-resistant HIV is rare and does not contribute substantially to therapy failure in a large European cohort
por: Bartha, István, et al.
Publicado: (2013)

Clinical Evaluation of Rega 8: An Updated Genotypic Interpretation System That Significantly Predicts HIV-Therapy Response
por: Vercauteren, Jurgen, et al.
Publicado: (2013)

Correction: Antiretroviral Therapy Optimisation without Genotype Resistance Testing: A Perspective on Treatment History Based Models
por: Prosperi, Mattia C. F., et al.
Publicado: (2011)

Antiretroviral Therapy Optimisation without Genotype Resistance Testing: A Perspective on Treatment History Based Models
por: Prosperi, Mattia C. F., et al.
Publicado: (2010)

Mapping the genomic diversity of HCV subtypes 1a and 1b: Implications of structural and immunological constraints for vaccine and drug development
por: Cuypers, Lize, et al.
Publicado: (2016)

RegaDB: community-driven data management and analysis for infectious diseases
por: Libin, Pieter, et al.
Publicado: (2013)

HIV-1 Gag C-terminal amino acid substitutions emerging under selective pressure of protease inhibitors in patient populations infected with different HIV-1 subtypes
por: Li, Guangdi, et al.
Publicado: (2014)

Quality Control of Next-Generation Sequencing-Based HIV-1 Drug Resistance Data in Clinical Laboratory Information Systems Framework
por: Capina, Rupert, et al.
Publicado: (2020)

The EuResist expert model for customised HAART optimisation: 2010 update and extension to newest compounds
por: Pironti, A, et al.
Publicado: (2010)

Quantifying Next Generation Sequencing Sample Pre-Processing Bias in HIV-1 Complete Genome Sequencing
por: Vrancken, Bram, et al.
Publicado: (2016)

Clinical use, efficacy, and durability of maraviroc for antiretroviral therapy in routine care: A European survey
por: De Luca, Andrea, et al.
Publicado: (2019)

The Genealogical Population Dynamics of HIV-1 in a Large Transmission Chain: Bridging within and among Host Evolutionary Rates
por: Vrancken, Bram, et al.
Publicado: (2014)

Sub-Epidemics Explain Localized High Prevalence of Reduced Susceptibility to Rilpivirine in Treatment-Naive HIV-1-Infected Patients: Subtype and Geographic Compartmentalization of Baseline Resistance Mutations
por: Theys, Kristof, et al.
Publicado: (2016)

PhyloGeoTool: interactively exploring large phylogenies in an epidemiological context
por: Libin, Pieter, et al.
Publicado: (2017)

Nucleoside Reverse-Transcriptase Inhibitor Resistance Mutations Predict Virological Failure in Human Immunodeficiency Virus-Positive Patients During Lamivudine Plus Dolutegravir Maintenance Therapy in Clinical Practice
por: Borghetti, Alberto, et al.
Publicado: (2021)

Estimating the individualized HIV-1 genetic barrier to resistance using a nelfinavir fitness landscape
por: Theys, Kristof, et al.
Publicado: (2010)

Performance of an In-House Human Immunodeficiency Virus Type 1 Genotyping System for Assessment of Drug Resistance in Cuba
por: Alemán, Yoan, et al.
Publicado: (2015)

Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study
por: Focà, Emanuele, et al.
Publicado: (2016)

Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in Italy
por: Cuypers, Lize, et al.
Publicado: (2017)

Determinants of HIV-1 Late Presentation in Patients Followed in Europe
por: Miranda, Mafalda N. S., et al.
Publicado: (2021)

Efficacy, Convenience, Safety and Durability of DTG-Based Antiretroviral Therapies: Evidence from a Prospective Study by the Italian MaSTER Cohort
por: Fusco, Paolo, et al.
Publicado: (2023)

Cellular HIV-1 DNA Levels in Drug Sensitive Strains Are Equivalent to Those in Drug Resistant Strains in Newly-Diagnosed Patients in Europe
por: Demetriou, Victoria L., et al.
Publicado: (2010)

The global burden of HIV-1 drug resistance in the past 20 years
por: Zazzi, Maurizio, et al.
Publicado: (2018)

High frequency of antiviral drug resistance and non-b subtypes in HIV-1 patients failing antiviral therapy in Cuba
por: Kouri, Vivian, et al.
Publicado: (2014)

Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial
por: Fabbiani, Massimiliano, et al.
Publicado: (2014)

Virological Mechanisms in the Coinfection between HIV and HCV
por: Liberto, Maria Carla, et al.
Publicado: (2015)

Earlier Initiation of Antiretroviral Treatment Coincides With an Initial Control of the HIV-1 Sub-Subtype F1 Outbreak Among Men-Having-Sex-With-Men in Flanders, Belgium
por: Vinken, Lore, et al.
Publicado: (2019)

Convenience, efficacy, safety, and durability of INSTI-based antiretroviral therapies: evidence from the Italian MaSTER cohort
por: Rich, Shannan N., et al.
Publicado: (2023)

Comparative determination of HIV-1 co-receptor tropism by Enhanced Sensitivity Trofile, gp120 V3-loop RNA and DNA genotyping
por: Prosperi, Mattia CF, et al.
Publicado: (2010)

Virological effectiveness and CD4+ T-cell increase over early and late courses in HIV infected patients on antiretroviral therapy: focus on HCV and anchor class received
por: Motta, Davide, et al.
Publicado: (2012)

Increasing risk behaviour can outweigh the benefits of antiretroviral drug treatment on the HIV incidence among men-having-sex-with-men in Amsterdam
por: Mei, Shan, et al.
Publicado: (2011)

Selecting anti-HIV therapies based on a variety of genomic and clinical factors
por: Rosen-Zvi, Michal, et al.
Publicado: (2008)

CRF19_cpx is an Evolutionary fit HIV-1 Variant Strongly Associated With Rapid Progression to AIDS in Cuba
por: Kouri, Vivian, et al.
Publicado: (2015)

A Prognostic Model for Estimating the Time to Virologic Failure in HIV-1 Infected Patients Undergoing a New Combination Antiretroviral Therapy Regimen
por: Prosperi, Mattia CF, et al.
Publicado: (2011)

Two Distinct Hepatitis C Virus Genotype 1a Clades Have Different Geographical Distribution and Association With Natural Resistance to NS3 Protease Inhibitors
por: De Luca, Andrea, et al.
Publicado: (2015)

Predictors of virological failure in HIV‐1‐infected patients switching to dolutegravir maintenance monotherapy
por: Wijting, IEA, et al.
Publicado: (2018)

More virological failure with lamivudine than emtricitabine in efavirenz and nevirapine regimens in the Dutch nationwide HIV Cohort
por: Rokx, Casper, et al.
Publicado: (2014)

Genetic Diversity and Selective Pressure in Hepatitis C Virus Genotypes 1–6: Significance for Direct-Acting Antiviral Treatment and Drug Resistance
por: Cuypers, Lize, et al.
Publicado: (2015)

A prospect on the use of antiviral drugs to control local outbreaks of COVID-19
por: Torneri, Andrea, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e6ll4ju7ire6t7pf4m1hpboj2l